GENETIC ANALYSIS OF RICKETTSIA PROWAZEKII

普瓦泽克立克次体的遗传分析

基本信息

  • 批准号:
    7233571
  • 负责人:
  • 金额:
    $ 38.47万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1983
  • 资助国家:
    美国
  • 起止时间:
    1983-07-01 至 2010-03-31
  • 项目状态:
    已结题

项目摘要

PROVIDED. Members of the genus Rickettsia are the etiologic agents of rocky mountainand other spotted fevers and endemic, scrub, and epidemic typhus, diseases that pose a pernicious health threat worldwide. Rickettsiaprowazekii, thz etiologic agent of epidemic typhus is an obligate intracellular parasitic bacterium that can grow only within the cytoplasm of a eucaryotic host cell. The ability of rickettsiae to exploit this intracellularniche in animalsas diverse as arthropods and humans and to subsequently cause serious human disease provides the impetus for this study. This proposal focuses on the development and application of genetic techniques to address questions about the pathogenic bacterium R. prowazekii and its obligate intracytoplasmic existence. It exploits the availability of the R. prowazekii genome sequence and the development of rickettsial genetic technologies to test hypotheses related torickettsial gene function, DNA replication, and pathogenic mechanisms. In Specific Aim 1 our goal is to capitalize on a rickettsial transformation system and the identification of a selectable antibiotic resistance gene that can beexpressed inR.prowazekii to discriminate, via knockouts, essential function at the level of single genes. Specifically targeted genes include those that encode products withhomology to known virulencegenes of other bacteria, genes hypothesized to be expressed only in the arthropod vector, genes hypothesized to be non-functional and part of the process of rickettsial reductiveevolution,and finally, genes with homologs within the R.prowazekii genome. In addition, a transposon-based approach will be used to generate random insertion mutants. In Specific Aim 2 our goal is to isolate the functional origin of replication. One approach will attempt to generate a rickettsial minichromosome by linkingputative origin fragments with the selectable erythromycin-resistant gene, ereB. An alternate method will identify the originby the bindingof rickettsial DnaA. Specific Aim 3 will continue our characterization of transcription termination and our identificationof rickettsialtranscriptional changes that occur just prior to lysis of the host cell. Using ribonuclease protection studies we will determine whether these changes reflect a general property of the rickettsiae by examining additional non-intrinsic termination sites and the effect of cell number on terminationat these sites. Modulation of Rho and its correlation to these changes will be: assessed.
提供。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID WOOD其他文献

DAVID WOOD的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID WOOD', 18)}}的其他基金

Gene expression in stage-specific populations of Rickettsia prowazekii
普瓦泽基立克次体特定阶段群体的基因表达
  • 批准号:
    8425189
  • 财政年份:
    2013
  • 资助金额:
    $ 38.47万
  • 项目类别:
Gene expression in stage-specific populations of Rickettsia prowazekii
普瓦泽基立克次体特定阶段群体的基因表达
  • 批准号:
    8606398
  • 财政年份:
    2013
  • 资助金额:
    $ 38.47万
  • 项目类别:
SUPPORTING INFLUENZA VACCINE INTRODUCTION IN LOW-MIDDLE INCOME COUNTRIES
支持中低收入国家引进流感疫苗
  • 批准号:
    8331152
  • 财政年份:
    2011
  • 资助金额:
    $ 38.47万
  • 项目类别:
SUPPORTING INFLUENZA VACCINE INTRODUCTION IN LOW-MIDDLE INCOME COUNTRIES
支持中低收入国家引进流感疫苗
  • 批准号:
    8332011
  • 财政年份:
    2011
  • 资助金额:
    $ 38.47万
  • 项目类别:
SUPPORTING INFLUENZA VACCINE INTRODUCTION IN LOW-MIDDLE INCOME COUNTRIES
支持中低收入国家引进流感疫苗
  • 批准号:
    8307704
  • 财政年份:
    2011
  • 资助金额:
    $ 38.47万
  • 项目类别:
GENETIC ANALYSIS OF RICKETTSIA PROWAZEKII
普瓦泽克立克次体的遗传分析
  • 批准号:
    8053672
  • 财政年份:
    2010
  • 资助金额:
    $ 38.47万
  • 项目类别:
Global Analysis of the Rickettsia prowazekii Proteome
普瓦泽基立克次体蛋白质组的整体分析
  • 批准号:
    6837116
  • 财政年份:
    2003
  • 资助金额:
    $ 38.47万
  • 项目类别:
Global Analysis of the Rickettsia prowazekii Proteome
普瓦泽基立克次体蛋白质组的整体分析
  • 批准号:
    7157623
  • 财政年份:
    2003
  • 资助金额:
    $ 38.47万
  • 项目类别:
Global Analysis of the Rickettsia prowazekii Proteome
普瓦泽基立克次体蛋白质组的整体分析
  • 批准号:
    7005832
  • 财政年份:
    2003
  • 资助金额:
    $ 38.47万
  • 项目类别:
Global Analysis of the Rickettsia prowazekii Proteome
普瓦泽基立克次体蛋白质组的整体分析
  • 批准号:
    6672487
  • 财政年份:
    2003
  • 资助金额:
    $ 38.47万
  • 项目类别:

相似海外基金

Ecological and Evolutionary Drivers of Antibiotic Resistance in Patients
患者抗生素耐药性的生态和进化驱动因素
  • 批准号:
    EP/Y031067/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.47万
  • 项目类别:
    Research Grant
Collaborative Research: Leveraging the interactions between carbon nanomaterials and DNA molecules for mitigating antibiotic resistance
合作研究:利用碳纳米材料和 DNA 分子之间的相互作用来减轻抗生素耐药性
  • 批准号:
    2307222
  • 财政年份:
    2024
  • 资助金额:
    $ 38.47万
  • 项目类别:
    Standard Grant
Molecular Epidemiology of Antibiotic Resistance in Clostridioides difficile
艰难梭菌抗生素耐药性的分子流行病学
  • 批准号:
    502587
  • 财政年份:
    2024
  • 资助金额:
    $ 38.47万
  • 项目类别:
Collaborative Research: Leveraging the interactions between carbon nanomaterials and DNA molecules for mitigating antibiotic resistance
合作研究:利用碳纳米材料和 DNA 分子之间的相互作用来减轻抗生素耐药性
  • 批准号:
    2307223
  • 财政年份:
    2024
  • 资助金额:
    $ 38.47万
  • 项目类别:
    Standard Grant
The roles of a universally conserved DNA-and RNA-binding domain in controlling MRSA virulence and antibiotic resistance
普遍保守的 DNA 和 RNA 结合域在控制 MRSA 毒力和抗生素耐药性中的作用
  • 批准号:
    MR/Y013131/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.47万
  • 项目类别:
    Research Grant
Determining structural dynamics of membrane proteins in their native environment: focus on bacterial antibiotic resistance
确定膜蛋白在其天然环境中的结构动力学:关注细菌抗生素耐药性
  • 批准号:
    MR/X009580/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.47万
  • 项目类别:
    Fellowship
CAREER: Systems Microbiology and InterdiscipLinary Education for Halting Environmental Antibiotic Resistance Transmission (SMILE HEART)
职业:阻止环境抗生素耐药性传播的系统微生物学和跨学科教育(SMILE HEART)
  • 批准号:
    2340818
  • 财政年份:
    2024
  • 资助金额:
    $ 38.47万
  • 项目类别:
    Continuing Grant
Reinforcing the battle at the bacterial cell wall: Structure-guided characterization and inhibition of beta-lactam antibiotic resistance signalling mechanisms
加强细菌细胞壁的战斗:β-内酰胺抗生素耐药信号机制的结构引导表征和抑制
  • 批准号:
    480022
  • 财政年份:
    2023
  • 资助金额:
    $ 38.47万
  • 项目类别:
    Operating Grants
The spread of antibiotic resistance in bacteria-plasmid networks
抗生素耐药性在细菌-质粒网络中的传播
  • 批准号:
    BB/X010473/1
  • 财政年份:
    2023
  • 资助金额:
    $ 38.47万
  • 项目类别:
    Fellowship
An RNA Nanosensor for the Diagnosis of Antibiotic Resistance in M. Tuberculosis
用于诊断结核分枝杆菌抗生素耐药性的 RNA 纳米传感器
  • 批准号:
    10670613
  • 财政年份:
    2023
  • 资助金额:
    $ 38.47万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了